TY - JOUR
T1 - Progression of immunoglobulin G4-related disease to systematic lupus erythematosus after gastric cancer surgery
T2 - A case report
AU - Arai, Haruna
AU - Hayashi, Hiroki
AU - Ogata, Soshiro
AU - Uto, Kenichi
AU - Saegusa, Jun
AU - Takahashi, Kazuo
AU - Koide, Shigehisa
AU - Inaguma, Daijyo
AU - Hasegawa, Midori
AU - Yuzawa, Yukio
N1 - Publisher Copyright:
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
PY - 2018/12
Y1 - 2018/12
N2 - Rationale: Immunoglobulin G4 related disease (IgG4-RD) rarely coexists with other autoimmune diseases, though we had a patient whose primary clinical problem was shifted from IgG4-RD to systemic lupus erythematosus (SLE) after gastrectomy. The present paper aimed to report pathological findings and clinical course of the patient. Patient concerns: The patient was a male aged 74 years old with gastric cancer characterized by the following symptoms: Raynaud phenomenon, polyarthralgia, and swollen parotid glands on both sides. Before gastrectomy, laboratory examination results showed renal dysfunction, hypocomplementemia, antinuclear antibodies (ANAs) positivity, and elevated serum IgG and IgG4 levels. Diagnosis: Based on postoperative renal biopsy showing severe plasma cell infiltration with tubulointerstitial fibrosclerosis, the patient was diagnosed with IgG4-RD. Despite significant improvement in renal function and reduction in parotid gland swelling during the postoperative follow-up period, after 7 months of the gastrectomy, anti-DNA antibody levels were increased and serositis was detected, which indicated the onset of SLE. IgG4-type ANA were also detected in the sera of the patient. Interventions: Treatment by oral prednisolone at 30 mg/day was initiated. Outcomes: Pericardial fluid, pleural effusions, and thickening of the gallbladder wall improved after 3 months of treatment according to computed tomography. Lessons: This study presented a rare case of comorbidity, wherein the patient’s primary problem progressed from IgG4-type ANA-positive IgG4-RD to SLE after excision of gastric cancer.
AB - Rationale: Immunoglobulin G4 related disease (IgG4-RD) rarely coexists with other autoimmune diseases, though we had a patient whose primary clinical problem was shifted from IgG4-RD to systemic lupus erythematosus (SLE) after gastrectomy. The present paper aimed to report pathological findings and clinical course of the patient. Patient concerns: The patient was a male aged 74 years old with gastric cancer characterized by the following symptoms: Raynaud phenomenon, polyarthralgia, and swollen parotid glands on both sides. Before gastrectomy, laboratory examination results showed renal dysfunction, hypocomplementemia, antinuclear antibodies (ANAs) positivity, and elevated serum IgG and IgG4 levels. Diagnosis: Based on postoperative renal biopsy showing severe plasma cell infiltration with tubulointerstitial fibrosclerosis, the patient was diagnosed with IgG4-RD. Despite significant improvement in renal function and reduction in parotid gland swelling during the postoperative follow-up period, after 7 months of the gastrectomy, anti-DNA antibody levels were increased and serositis was detected, which indicated the onset of SLE. IgG4-type ANA were also detected in the sera of the patient. Interventions: Treatment by oral prednisolone at 30 mg/day was initiated. Outcomes: Pericardial fluid, pleural effusions, and thickening of the gallbladder wall improved after 3 months of treatment according to computed tomography. Lessons: This study presented a rare case of comorbidity, wherein the patient’s primary problem progressed from IgG4-type ANA-positive IgG4-RD to SLE after excision of gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=85058920029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058920029&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000013545
DO - 10.1097/MD.0000000000013545
M3 - Article
C2 - 30572454
AN - SCOPUS:85058920029
SN - 0025-7974
VL - 97
JO - Medicine (United States)
JF - Medicine (United States)
IS - 51
M1 - e13545
ER -